A novel approach to the pharmacology of analgesics

American Journal of Medicine

Volumn 101, Issue 1 A, 1996, Pages S40-S46

  Raffa, Robert B ^a,b  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; DEXTROPROPOXYPHENE; IMIPRAMINE; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; SEROTONIN; TRAMADOL;

ANALGESIA; ANALGESIC ACTIVITY; DRUG MECHANISM; EUROPE; HUMAN; NONHUMAN; PAIN; PRIORITY JOURNAL; REVIEW; UNITED STATES;

EID: 0029757678     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(96)90034-0     Document Type: Review

References (33)

1. Friderichs E, Felgenhauer F, Jongschaap P, Osterloh G. Pharmacological studies on analgesia, dependence on and tolerance of tramadol, a potent analgesic drug. Arzneimittelforschung/Drug Res. 1978;28:122-134.
2. Hennies H-H, Friderichs E, Schneider J. Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids. Arzneimittelforschung/Drug Res. 1988;38:877-880.
3. Arend I, Von Arnim B, Nijssen J, Scheele J, Flohé L. Tramadol and pentazocine in a clinical double-blind crossover comparison. Arzneimittelforschung/ Drug Res. 1978;28:199-208.
4. Lehmann KA, Kratzenberg U, Schroeder-Bark B, Horrichs-Haermeyer G. Postoperative patient-controlled analgesia with tramadol: analgesic efficacy and minimum effective concentrations. Clin J Pain. 1990;6:212-220.
5. Muller-Limmroth W, Krueger H. The effect of tramadol on psychic and psychomotor performance in man. Arzneimittelforschung/Drug Res. 1978;28:179-180.
6. Schenck EG, Arend I. The effect of tramadol in an open clinical trial. Arzneimittelforschung/Drug Res. 1978;28:209-212.
7. Vogel W, Burchardi H, Sihler K, Valic L. The effect of tramadol, a new analgesic, on respiration and cardiovascular function. Arzneimittelforschung/Drug Res. 1978;28:183-186.
8. Flohé L, Arend I, Cogal A, Richter W, Simon W. Clinical study on the development of dependency after long-term treatment with tramadol. Arzneimittelforscnung/Drug Res. 1978;28:213-217.
9. Richter W, Barth H, Flohé L, Giertz H. Clinical investigation on the development of dependence during oral therapy with tramadol. Arzneimittelforschung/ Drug Res. 1985;35:1742-1744.
10. Preston KL, Jasinski DR, Testa M. Abuse potential and pharmacological comparison of tramadol and morphine. Drug Alcohol Depend. 1991;27:7-17.
11. Keup W. Missbrauchsmuster bei abhängigkeit von alkohol, medikamenten und drogen: frünwarnsystem-daten für die bundesrepublik Deutschland. 1976-1990. Lambertus, Freiberg im Breisgau, 1993.
12. Driessen B, Reimann W, Giertz H. Effects of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitro. Br J Pharmacol. 1993;108:806-811.
13. Driessen B, Reimann W. Interaction of the central analgesic, tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro. Br J Pharmacol. 1992;105:147-151.
14. Friderichs E, Reimann W, Selve N. Contribution of both enantiomers to antinociception of the centrally acting analgesic tramadol. Naunyn Schmiedeberg's Arch Pharmacol. 1992;346:R36.
15. Raffa RB, Friderichs E, Reimann W, et al. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exp Ther. 1993;267:331-340.
16. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an "atypical" opioid analgesic. J Pharmacol Exp Ther. 1992;260:275-285.
17. Reimann W, Hennies H-H. Inhibition of spinal noradrenaline uptake in rats by the centrally acting analgesic tramadol. Biochem Pharmacol. 1994; 47:2289-2293.
18. Reimann W, Driessen B, Schlütz H. Does a non-opioid component contribute to the efficacy of the central analgesic tramadol? 10th European Winter Conference on Brain Research, March 3-10, 1990.
19. Sevcik J, Nieber K, Driessen B, Illes P. Effects of the central analgesic tramadol and its main metabolite, O-desmethyltramadol, on rat locus coeruleus neurones. Br J Pharmacol. 1993;110:169-176.
20. Collier HO, Dinneen LC, Johnson CA, Schneider C. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol. 1968;32:295-310.
21. Eddy NB, Leimbach D. Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines. J Pharmacol Exp Ther. 1953;107:385-393.
22. D'Amour FE, Smith DL. A method for determining loss of pain sensation. J Pharmacol Exp Ther. 1941;72:74-79.
23. VonVoigtlander PF, Lewis RA. Air-induced writhing: a rapid broad spectrum assay for analgesics. Drug Dev Res. 1982;2:577-581.
24. Erlacin S, Frankus E, Lintz W. Metabolism of tramadol in man and animals. Naunyn Schmiedeberg's Arch Pharmacol. 1980;313(Suppl):R202.
25. Lintz W, Erlacin S, Frankus E, Uragg H. Biotransformation of tramadol in man and animal. Arzneimittelforschung/Drug Res. 1981;31:1932-1943.
26. 1 serum levels with antinociceptive activity in mice. Naunyn Schmiedeberg's Arch Pharmacol. 1991;343:R9.
27. Collart L, Luthy C, Dayer P. Partial inhibition of tramadol antinociceptive effect by naloxone in man. Br J Clin Pharmacol. 1993;35:73P.
28. Collart L, Luthy C, Dayer P. Multimodal analgesic effect of tramadol. Clin Pharmacol Ther. 1993;53:223.
29. Paar WD, Frankus P, Dengler HJ. The metabolism of tramadol by human liver microsomes. Clin Invest. 1992;70:708-710.
30. Arunlakshana O, Schild HO. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959;14:48-58.
31. Mattia A, Vanderah T, Raffa RB, Vaught JL, Tallarida RJ, Porreca F. Characterization of the unusual antinociceptive profile of tramadol in mice. Drug Dev Res. 1993;28:176-182.
32. Kayser V, Besson J-M, Guilbaud G. Effects of the analgesic agent tramadol in normal and arthritic rats: comparison with the effects of different opioids, including tolerance and cross-tolerance to morphine. Eur J Pharmacol. 1991;195:37-45.
33. Data on file. The RW Johnson Pharmaceutical Research Institute, Spring House, PA;. 1992.